Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
CONCLUSIONS: ACEi or ARB may make little or no difference to all-cause and cardiovascular death compared to placebo or no treatment in people with diabetes and kidney disease but may prevent kidney failure. ARB may prevent the doubling of SCr and the progression from microalbuminuria to macroalbuminuria compared with a placebo or no treatment. Despite the international guidelines suggesting not combining ACEi and ARB treatment, the effects of ACEi or ARB monotherapy compared to dual therapy have not been adequately assessed. The limited data availability and the low quality of the included studies prevented the assessment ...
Source: Cochrane Database of Systematic Reviews - April 29, 2024 Category: General Medicine Authors: Patrizia Natale Suetonia C Palmer Sankar D Navaneethan Jonathan C Craig Giovanni Fm Strippoli Source Type: research
Current status of liver transplantation for human immunodeficiency virus-infected patients in mainland China
This study provides an overview of the current landscape of HIV-positive patients receiving liver transplantation (LT) in mainland China. To date, our transplant center has conducted LT for eight end-stage liver disease patients co-infected with HIV, and all but one, who died two months postoperatively due to sepsis and progressive multi-organ failure, have survived. Comparative analysis with hepatitis B virus-infected patients during the same period revealed no statistically significant differences in acute rejection reactions, cytomegalovirus infection, bacteremia, pulmonary infections, acute kidney injury, new-onset can...
Source: World Journal of Gastroenterology - April 29, 2024 Category: Gastroenterology Authors: Jian-Xin Tang Dong Zhao Source Type: research
Results of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma(MM) and Renal Impairment: A Retrospective Single-Center Study
Conclusion: Auto-HSCT is a safe and effective treatment for patients with MM complicated by acute kidney injury. Fourteen of 23 (61%) patients became dialysis-independent.PMID:38680711 | PMC:PMC11055427 | DOI:10.18502/ijhoscr.v18i1.14745 (Source: Herpes)
Source: Herpes - April 29, 2024 Category: Infectious Diseases Authors: Maiia Soloveva Maxim Solovev Daria Mironova Larisa Mendeleeva Source Type: research
Zinc and Chronic Kidney Disease: A Review
J Nutr Sci Vitaminol (Tokyo). 2024;70(2):98-105. doi: 10.3177/jnsv.70.98.ABSTRACTChronic kidney disease (CKD) poses a major global public health challenge. The World Health Organization's data shows that CKD affects about 10% of the world's population, particularly in low- and middle-income countries. Due to limited access to diagnosis and treatment, CKD has become the 12th leading cause of death worldwide. The advanced stage of CKD can lead to kidney failure, which is clinically referred to as end-stage renal disease (ESRD). In such cases, patients can only sustain life through dialysis or kidney transplantation. However,...
Source: Journal of Nutritional Science and Vitaminology - April 29, 2024 Category: Nutrition Authors: Wanqiu Chen Hongtao Lu Yajing Ying Hongxia Li Hui Shen Jianming Cai Source Type: research
Results of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma(MM) and Renal Impairment: A Retrospective Single-Center Study
Conclusion: Auto-HSCT is a safe and effective treatment for patients with MM complicated by acute kidney injury. Fourteen of 23 (61%) patients became dialysis-independent.PMID:38680711 | PMC:PMC11055427 | DOI:10.18502/ijhoscr.v18i1.14745 (Source: Herpes)
Source: Herpes - April 29, 2024 Category: Infectious Diseases Authors: Maiia Soloveva Maxim Solovev Daria Mironova Larisa Mendeleeva Source Type: research
Current status of liver transplantation for human immunodeficiency virus-infected patients in mainland China
This study provides an overview of the current landscape of HIV-positive patients receiving liver transplantation (LT) in mainland China. To date, our transplant center has conducted LT for eight end-stage liver disease patients co-infected with HIV, and all but one, who died two months postoperatively due to sepsis and progressive multi-organ failure, have survived. Comparative analysis with hepatitis B virus-infected patients during the same period revealed no statistically significant differences in acute rejection reactions, cytomegalovirus infection, bacteremia, pulmonary infections, acute kidney injury, new-onset can...
Source: World Journal of Gastroenterology : WJG - April 29, 2024 Category: Gastroenterology Authors: Jian-Xin Tang Dong Zhao Source Type: research
Cardiac Amyloidosis: A Contemporary Review of Medical and Surgical Therapy
Curr Cardiol Rev. 2024;20(2):72-81. doi: 10.2174/011573403X240302230925043500.ABSTRACTAmyloidosis is a systemic disease initiated by deposition of misfolded proteins in the extracellular space, due to which multiple organs may be affected concomitantly. Cardiac amyloidosis, however, remains a major cause of morbidity and mortality in this population due to infiltrative /restrictive cardiomyopathy. This review attempts to focus on contemporary medical and surgical therapies for the different types of cardiac amyloidosis. Amyloidosis affecting the heart are predominantly of the transthyretin type (acquired in the older or ge...
Source: Current Cardiology Reviews - April 29, 2024 Category: Cardiology Authors: Drew Brownell Aiswarya J Pillai Nandini Nair Source Type: research
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
CONCLUSIONS: ACEi or ARB may make little or no difference to all-cause and cardiovascular death compared to placebo or no treatment in people with diabetes and kidney disease but may prevent kidney failure. ARB may prevent the doubling of SCr and the progression from microalbuminuria to macroalbuminuria compared with a placebo or no treatment. Despite the international guidelines suggesting not combining ACEi and ARB treatment, the effects of ACEi or ARB monotherapy compared to dual therapy have not been adequately assessed. The limited data availability and the low quality of the included studies prevented the assessment ...
Source: Cochrane Database of Systematic Reviews - April 29, 2024 Category: General Medicine Authors: Patrizia Natale Suetonia C Palmer Sankar D Navaneethan Jonathan C Craig Giovanni Fm Strippoli Source Type: research
Current status of liver transplantation for human immunodeficiency virus-infected patients in mainland China
This study provides an overview of the current landscape of HIV-positive patients receiving liver transplantation (LT) in mainland China. To date, our transplant center has conducted LT for eight end-stage liver disease patients co-infected with HIV, and all but one, who died two months postoperatively due to sepsis and progressive multi-organ failure, have survived. Comparative analysis with hepatitis B virus-infected patients during the same period revealed no statistically significant differences in acute rejection reactions, cytomegalovirus infection, bacteremia, pulmonary infections, acute kidney injury, new-onset can...
Source: World Journal of Gastroenterology - April 29, 2024 Category: Gastroenterology Authors: Jian-Xin Tang Dong Zhao Source Type: research
Effect of pre-transplantation use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in kidney transplant recipients-propensity score-matched analysis
CONCLUSIONS: In KT, the preoperative use of ACEi/ARBs did not significantly affect clinical outcomes including delayed graft function, postoperative renal function, hyperkalemia events, incidence of rejection, and graft survival rates compared to the patients who did not receive ACEi/ARBs.PMID:38684638 | DOI:10.1007/s40620-024-01938-3 (Source: Journal of Nephrology)
Source: Journal of Nephrology - April 29, 2024 Category: Urology & Nephrology Authors: Jaeyun Lee Chan-Young Jung Hyosang Kim Hwa Jung Kim Youngmin Ko Hyunwook Kwon Sung Shin Young Hoon Kim Su-Kil Park Chung Hee Baek Source Type: research
Primary peritoneal carcinoma presented with abdominal pain in patient with kidney transplantation
Korean J Intern Med. 2024 Apr 29. doi: 10.3904/kjim.2023.254. Online ahead of print.NO ABSTRACTPMID:38680009 | DOI:10.3904/kjim.2023.254 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - April 29, 2024 Category: Internal Medicine Authors: Eunmi Jo Sang Heon Song Source Type: research
Zinc and Chronic Kidney Disease: A Review
J Nutr Sci Vitaminol (Tokyo). 2024;70(2):98-105. doi: 10.3177/jnsv.70.98.ABSTRACTChronic kidney disease (CKD) poses a major global public health challenge. The World Health Organization's data shows that CKD affects about 10% of the world's population, particularly in low- and middle-income countries. Due to limited access to diagnosis and treatment, CKD has become the 12th leading cause of death worldwide. The advanced stage of CKD can lead to kidney failure, which is clinically referred to as end-stage renal disease (ESRD). In such cases, patients can only sustain life through dialysis or kidney transplantation. However,...
Source: Journal of Nutritional Science and Vitaminology - April 29, 2024 Category: Nutrition Authors: Wanqiu Chen Hongtao Lu Yajing Ying Hongxia Li Hui Shen Jianming Cai Source Type: research
Primary peritoneal carcinoma presented with abdominal pain in patient with kidney transplantation
Korean J Intern Med. 2024 Apr 29. doi: 10.3904/kjim.2023.254. Online ahead of print.NO ABSTRACTPMID:38680009 | DOI:10.3904/kjim.2023.254 (Source: The Korean Journal of Internal Medicine)
Source: The Korean Journal of Internal Medicine - April 29, 2024 Category: Internal Medicine Authors: Eunmi Jo Sang Heon Song Source Type: research
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
CONCLUSIONS: ACEi or ARB may make little or no difference to all-cause and cardiovascular death compared to placebo or no treatment in people with diabetes and kidney disease but may prevent kidney failure. ARB may prevent the doubling of SCr and the progression from microalbuminuria to macroalbuminuria compared with a placebo or no treatment. Despite the international guidelines suggesting not combining ACEi and ARB treatment, the effects of ACEi or ARB monotherapy compared to dual therapy have not been adequately assessed. The limited data availability and the low quality of the included studies prevented the assessment ...
Source: Cochrane Database of Systematic Reviews - April 29, 2024 Category: General Medicine Authors: Patrizia Natale Suetonia C Palmer Sankar D Navaneethan Jonathan C Craig Giovanni Fm Strippoli Source Type: research
Current status of liver transplantation for human immunodeficiency virus-infected patients in mainland China
This study provides an overview of the current landscape of HIV-positive patients receiving liver transplantation (LT) in mainland China. To date, our transplant center has conducted LT for eight end-stage liver disease patients co-infected with HIV, and all but one, who died two months postoperatively due to sepsis and progressive multi-organ failure, have survived. Comparative analysis with hepatitis B virus-infected patients during the same period revealed no statistically significant differences in acute rejection reactions, cytomegalovirus infection, bacteremia, pulmonary infections, acute kidney injury, new-onset can...
Source: World Journal of Gastroenterology : WJG - April 29, 2024 Category: Gastroenterology Authors: Jian-Xin Tang Dong Zhao Source Type: research
